Jun 14, 2023 / 04:20PM GMT
Unidentified Analyst -
Thanks, everyone, for joining us Day 3 of the Goldman Sachs Global Healthcare Conference. And obviously, we're thrilled to be joined by the team from Apellis Pharmaceuticals. I mean, not a lot going on, so it's kind of show time for you all. I think I'll start with the first question, what's with the hat?
Cedric Francois - Apellis Pharmaceuticals, Inc. - Co-Founder, President, CEO & Director
Yes, I'm a big Boston Red Sox fan now...
Unidentified Company Representative -
Boston Soccer fan. That's awesome. Thank you.
Questions and Answers:
Unidentified Analyst -Amazing. Excellent. All right. So let's start at a very high level, then we'll kind of dive right into it. Walk us through how the launch of SYFOVRE, you're recently approved drug in geographic atrophy is progressing?
Cedric Francois - Apellis Pharmaceuticals, Inc. - Co-Founder, President, CEO & Director
Thank you so much, [Medwin], and thank you, everyone, for
Trustpilot
